The Emergence of General AI for Medicine | Dr. Peter Lee

Dr. Peter Lee is Corporate Vice President of Research and Incubations at Microsoft where he leads Microsoft Research and incubates new research-powered products and lines of business in areas such as artificial intelligence, computing foundations, health, and life sciences. He speaks and writes widely on science and technology trends, including the attached NEJM article “Benefits, Limits, and Risks of GPT-4 as an AI Chatbot for Medicine” and recently published a book with Dr. Isaac Kohane, “The AI Revolution in Medicine: GPT-4 and Beyond.”

Before joining Microsoft in 2010, he was at DARPA, where he established a new technology office that created operational capabilities in machine learning, data science, and computational social science. Prior to that, he was a professor and the head of the computer science department at Carnegie Mellon University. Dr. Lee is a member of the National Academy of Medicine and serves on the Boards of Directors of several institutes for the Allen Institute for Artificial Intelligence, the Brotman Baty Institute for Precision Medicine, and the Kaiser Permanente Bernard J. Tyson School of Medicine. He served on President Obama’s Commission on Enhancing National Cybersecurity and led studies for PCAST and the National Academies. He has testified before both the US House Science and Technology Committee and the US Senate Commerce Committee.